IFG Advisory’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
IFG Advisory's VRTX Position: Q2 2026 in Review
IFG Advisory opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 1,941 shares worth $964K. The stake represents 0.03% of the portfolio and ranks #435 among its holdings. This is a return to the name: IFG Advisory previously reported a position in VRTX as recently as Q4 2025.
IFG Advisory first reported a position in VRTX in Q4 2017 and has held it in 19 quarters since. The position peaked at $1.02M in Q2 2024. 1,758 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- IFG Advisory held 1,941 shares of Vertex Pharmaceuticals worth $964K as of Q2 2026.
- Vertex Pharmaceuticals was a new IFG Advisory position in Q2 2026.
- Vertex Pharmaceuticals made up 0.03% of IFG Advisory's portfolio in Q2 2026, its #435 holding.
- IFG Advisory first reported a position in Vertex Pharmaceuticals in Q4 2017 and has held it in 19 quarters since.
- IFG Advisory's Vertex Pharmaceuticals position peaked at $1.02M in Q2 2024.
- 1,758 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on IFG Advisory's 13F filing for Q2 2026, filed 14 Aug 2026.